America’s FDA Settles Lawsuit Over Ivermectin Warnings by Mark Eisenberg 05.04.2024 A lawsuit is underway as the misuse of #ivermectin as a COVID treatment continues. The article discusses the legal ramifications ...
Oxford’s DrugGPT: AI Revolutionizing Medication by Lilu Anderson 05.04.2024 Oxford University's DrugGPT, an AI tool to tackle prescription issues, could revolutionize healthcare, preventing mistakes, improving compliance, and reducing expenses.
Pfizer’s Debt Concerns Cast Doubt on Viking Therapeutics Acquisition by Mark Eisenberg 01.04.2024 Pfizer's interest in the weight loss market is uncertain due to its significant debt of over $70 billion and recent ...
Top Stocks to Buy in April: Viking, Brookfield Renewable, & UPS by Mark Eisenberg 31.03.2024 Investors seeking a blend of growth, income, and value should consider Viking, Brookfield Renewable, and UPS. While UPS faced a ...
Could AI Destroy Humans in Next Decade? U.S. Takes Steps by Lilu Anderson 30.03.2024 The U.S. lacks AI regulations, but is making progress in implementing safeguards. The Biden Administration introduced new guidance measures for ...
Cabaletta Bio Inc: Financial Report Reveals Market Insights by Mark Eisenberg 30.03.2024 Delve into a comprehensive financial analysis of Cabaletta Bio Inc, a key player in the NASDAQ exchange, with a strong ...
AI Transforms Online Pharmacy: Speed, Accuracy, Convenience by Lilu Anderson 29.03.2024 Amazon Pharmacy is leveraging AI for its same-day delivery service expansion in New York City and Los Angeles. AI helps ...
Congressional Plans for WuXi: Implications for Biotech by Lilu Anderson 29.03.2024 Stay updated on the latest in biotech with our newsletter and podcast. Boundless becomes the ninth biotech company to go ...
China’s AI Propaganda Mocks American Dream by Lilu Anderson 29.03.2024 The article discusses the declining American Dream and how people are increasingly seeking better opportunities outside the United States. This ...
Boundless Bio Makes $100M IPO Debut on Nasdaq by Mark Eisenberg 28.03.2024 Precision oncology company Boundless Bio is set to go public with a $100 million IPO on the Nasdaq, trading under ...